RCSB PDB
US$ 20.56
glp 1 agonist and blindness GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1s and Eye Health: What
Description
How this compares to Lilly and Novo Nordisk
Discover the benefits of GLP-1 medications like Wegovy and Zepbound at Austin Thyroid & Endocrinology
GRADE: LOW certainty)
A New Era in Health?
The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.
Take a deep dive into Eli Lilly's latest clinical GLP-1 results that sent shares soaring
